While drugs like Wegovy, Ozempic and Mounjaro are hailed for regulating blood sugar and helping people lose weight, new ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

A real-world analysis of nearly 7000 patients shows GLP-1s are associated with sharply lower death rates at 5 years in ...

For decades, immune-based cancer therapies have offered hope but also risk, with powerful tumor-fighting effects often ...

GLP-1 drugs such as Ozempic and Wegovy may extend the lives of colon cancer patients, according to a major UC San Diego study ...

The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor ...

Among 997 patients with lung cancer, only 35.1% met USPSTF screening criteria, while universal age-based screening (40-85 ...

Lung cancer remains the leading cause of cancer death, but advances in screening, surgery and personalized treatment are ...

A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor ...

The emergence of cancer drug resistance remains one of the most pressing problems in cancer care and there is a critical need ...

A new randomized trial from North Carolina suggests that digital tools like mPATH may slightly boost participation in CT lung ...